Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
12.53
+0.20 (1.62%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Y-mAbs Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 75.75 | 78.64 | 105.76 | 181.56 | 114.63 | 207.14 | Upgrade
|
Cash & Short-Term Investments | 75.75 | 78.64 | 105.76 | 181.56 | 114.63 | 207.14 | Upgrade
|
Cash Growth | -18.22% | -25.65% | -41.75% | 58.39% | -44.66% | 40.11% | Upgrade
|
Receivables | 20.59 | 22.45 | 12.53 | 7.71 | - | - | Upgrade
|
Inventory | 8.45 | 5.07 | 6.7 | 5.51 | - | - | Upgrade
|
Other Current Assets | 3.48 | 4.96 | 5.45 | 7.47 | 7.73 | 4.82 | Upgrade
|
Total Current Assets | 108.27 | 111.11 | 130.45 | 202.26 | 122.36 | 211.96 | Upgrade
|
Property, Plant & Equipment | 1.33 | 1.64 | 2.34 | 5.69 | 6.39 | 4.04 | Upgrade
|
Other Intangible Assets | 2.54 | 2.63 | 2.99 | 1.66 | - | - | Upgrade
|
Other Long-Term Assets | 11.17 | 12.49 | 5.68 | 3.17 | 3.29 | 0.37 | Upgrade
|
Total Assets | 123.32 | 127.87 | 141.46 | 212.78 | 132.05 | 216.37 | Upgrade
|
Accounts Payable | 6.73 | 6.06 | 14.18 | 13.55 | 9.37 | 8.52 | Upgrade
|
Accrued Expenses | 5.62 | 7.41 | 6.77 | 6.84 | 4.59 | 4.2 | Upgrade
|
Current Portion of Leases | 0.89 | 0.9 | 0.87 | 1.78 | 1.97 | 0.52 | Upgrade
|
Other Current Liabilities | 4.37 | 5.76 | 6.48 | 5.71 | 3.61 | 0.35 | Upgrade
|
Total Current Liabilities | 17.61 | 20.13 | 28.28 | 27.88 | 19.54 | 13.59 | Upgrade
|
Long-Term Leases | 0.29 | 0.52 | 0.9 | 1.85 | 2.01 | 1.71 | Upgrade
|
Other Long-Term Liabilities | 6.23 | 6.24 | 3.05 | 2.95 | 4.66 | 2.16 | Upgrade
|
Total Liabilities | 24.13 | 26.88 | 32.24 | 32.68 | 26.21 | 17.46 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 562.44 | 558 | 543.93 | 519.21 | 391.56 | 364.71 | Upgrade
|
Retained Earnings | -464.1 | -457.47 | -436.04 | -340.48 | -285.2 | -165.86 | Upgrade
|
Comprensive Income & Other | 0.85 | 0.45 | 1.33 | 1.37 | -0.53 | 0.05 | Upgrade
|
Shareholders' Equity | 99.19 | 100.99 | 109.22 | 180.11 | 105.84 | 198.9 | Upgrade
|
Total Liabilities & Equity | 123.32 | 127.87 | 141.46 | 212.78 | 132.05 | 216.37 | Upgrade
|
Total Debt | 1.18 | 1.42 | 1.77 | 3.63 | 3.98 | 2.23 | Upgrade
|
Net Cash (Debt) | 74.57 | 77.22 | 104 | 177.93 | 110.66 | 204.91 | Upgrade
|
Net Cash Growth | -18.19% | -25.75% | -41.55% | 60.80% | -46.00% | 38.60% | Upgrade
|
Net Cash Per Share | 1.71 | 1.77 | 2.38 | 4.12 | 2.76 | 5.82 | Upgrade
|
Filing Date Shares Outstanding | 43.88 | 43.78 | 43.68 | 43.71 | 43.53 | 39.76 | Upgrade
|
Total Common Shares Outstanding | 43.85 | 43.67 | 43.67 | 43.69 | 40.69 | 39.73 | Upgrade
|
Working Capital | 90.66 | 90.98 | 102.16 | 174.39 | 102.83 | 198.37 | Upgrade
|
Book Value Per Share | 2.26 | 2.31 | 2.50 | 4.12 | 2.60 | 5.01 | Upgrade
|
Tangible Book Value | 96.65 | 98.35 | 106.24 | 178.44 | 105.84 | 198.9 | Upgrade
|
Tangible Book Value Per Share | 2.20 | 2.25 | 2.43 | 4.08 | 2.60 | 5.01 | Upgrade
|
Source: S&P Capital IQ. Standard template.